Gene Therapy Market Size And Share

  • Report Code : TIPHE100001165
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Gene Therapy Market Share, Analysis, and Growth by 2031

Buy Now

Gene Therapy Market: Size and Share

Gene Therapy Market

  • CAGR (2023 - 2031)
    14.3%
  • Market Size 2023
    US$ 5.11 Billion
  • Market Size 2031
    US$ 25.69 Billion

Market Dynamics

GROWTH DRIVERS
  • Advances in genetic research
  • Growing demand for personalized medicine
FUTURE TRENDS
  • Expanding gene therapy research
  • Increasing clinical trials for genetic disorders
OPPORTUNITIES
  • Emerging research in genetic diseases and treatments
  • Expanding gene therapy pipeline

Market Segmentation

Vectors
  • Non-Viral Vectors and Viral Vectors
Indication
  • Neurological Diseases
  • Cancer
  • Duchenne Muscular Dystrophy
  • Hepatological Diseases
  • Other Indications
Delivery Mode
  • In-Vivo and Ex-Vivo

Gene Therapy Market Players Density: Understanding Its Impact on Business Dynamics

The Gene Therapy Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Gene Therapy Market are:

  1. Novartis AG
  2. Astellas Pharma Inc.
  3. Bristol-Myers Squibb Company
  4. Bluebird Bio Inc.
  5. Sanofi

Disclaimer: The companies listed above are not ranked in any particular order.


gene-therapy-market-speedometer

  • Get the Gene Therapy Market top key players overview